No abstract available
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antibodies, Monoclonal / immunology*
-
Antibodies, Monoclonal / pharmacology
-
Antibodies, Monoclonal, Humanized
-
Antibodies, Monoclonal, Murine-Derived / immunology*
-
Antibodies, Monoclonal, Murine-Derived / pharmacology
-
Antigens, CD20 / immunology*
-
Apoptosis / drug effects
-
Apoptosis / immunology
-
Cells, Cultured
-
Coculture Techniques
-
Enzyme Inhibitors / immunology
-
Enzyme Inhibitors / pharmacology
-
Humans
-
Killer Cells, Natural / immunology
-
Killer Cells, Natural / metabolism
-
Leukemia, Lymphocytic, Chronic, B-Cell / immunology
-
Leukemia, Lymphocytic, Chronic, B-Cell / metabolism
-
Leukemia, Lymphocytic, Chronic, B-Cell / pathology
-
Luminescent Measurements / methods
-
NADPH Oxidases / antagonists & inhibitors
-
NADPH Oxidases / immunology
-
NADPH Oxidases / metabolism
-
Neutrophils / drug effects
-
Neutrophils / immunology*
-
Neutrophils / metabolism
-
Onium Compounds / immunology
-
Onium Compounds / pharmacology
-
Reactive Oxygen Species / immunology*
-
Reactive Oxygen Species / metabolism
-
Rituximab
-
Tumor Cells, Cultured
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Antibodies, Monoclonal, Murine-Derived
-
Antigens, CD20
-
Enzyme Inhibitors
-
Onium Compounds
-
Reactive Oxygen Species
-
Rituximab
-
diphenyleneiodonium
-
NADPH Oxidases
-
ofatumumab